• Alternatives to potato sprout inhibition in critical need as U.S. moves towards eliminating CIPC
• CIPC, leading agrochemical product used for sprout suppression, was banned by EU in October
• MGRO’s patent focused on controlling vegetable, potato sprouting without harmful synthetic chemicals

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) has been granted an exclusive patent licensing from the University of Idaho in Moscow, Idaho (https://ibn.fm/vW2Ag). The patent is in connection with a natural biopesticide mustard-based treatment of stored produce and other foods. The ability the treatment may have for sprout suppression of potatoes is gaining particular interest in Idaho, which is the largest producer of potatoes in the country. “Alternatives to potato sprout inhibition are in critical need as the U.S. moves towards eliminating CIPC,” said MustGrow’s recently appointed scientific advisor, Dr. Matthew J. Morra, a leading world expert on value-added products derived from oilseeds. “Mustard-derived biopesticides rely on a natural sprout inhibitor that meets the needs of the potato industry without the negative human health consequences of current synthetic sprout inhibitors.” CIPC, or chlorpropham, is the leading agrochemical product used for sprout suppression, which is a critical element of potato storage. However, the chemical was banned by the European Union in October. Morra, a professor emeritus of soil biochemisty at the University of Idaho, is one of three inventors listed on MustGrow’s new patent. Potential for the patent is promising, with the current annual European sprout suppression market estimated at $64 million; globally the market is forecast to top $100 million. The recent ban could have a significant impact on that market, as potato farmers will be forced to refrigerate their produce. That alone could increase costs by an estimated $150 million each year in the EU, an increase most consider unsustainable. Growers are eager to identify alternative solutions. As a result, MustGrow’s exclusive licensing from the University of Idaho, which was granted earlier this year, has taken on added importance. Titled “Mustard Meal to Inhibit Sprouting,” the patent makes matter and method claims to use the mustard plant’s active ingredient, allyl isothiocyanate, in its efforts to control vegetable and potato sprouting without the use of harmful synthetic chemicals. MustGrow is working on providing options for the food-storage industry, particularly potatoes and grains, that combine its expertise in mustard-derived AITC with its newly secured patent. In this effort, the company has identified potential partners in relevant global regions based on food product characteristics and economics. MustGrow is an agriculture biotech company focused on providing natural, science-based biological solutions for high-value crops, including fruits and vegetables. MustGrow has designed and owns a U.S., EPA-approved natural solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. More than 110 independent tests have been completed validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s Pest Management Regulatory Agency (“PMRA”) as a biopesticide for high-value crops such as fruit and vegetables. MustGrow has now concentrated a liquid format, called TerraMG, which, with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. For more information, visit the company’s website at www.MustGrow.ca. NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

• Livestreaming platform allows artists to create exclusive artist-content channels, live-event streaming and promotional support
• New November artist sign-ups bring almost 500,000 fans, followers with them
• FDBL CEO notes “significant achievements at almost every turn as we build on the initial wave of response to the Fan Pass offering”

Friendable (OTC: FDBL) has announced that its proprietary live-streaming platform, Fan Pass, has reached a significant milestone: 50 exclusive artist channels are now live across the different genres available, adding to the overall total of 70 live artist channels (https://ibn.fm/4actX). New November artist sign-ups bring almost 500,000 fans and followers with them.

FDBL’s Fan Pass platform is designed to help artists engage with their fans around the world — and earn revenue while doing so. The livestreaming platform supports all different levels of artists, allowing them to create exclusive artist-content channels, live-event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which can serve as revenue streams for each artist. Once artists sign up on the Fan Pass platform and complete the onboarding process, including approving channel assets, graphics, content and imagery, they can schedule live performances, offer merchandise and invite fans to engage with them.

The recent milestone — 50 artists able to successfully complete onboarding since Fan Pass’s July launch — indicates the process has been streamlined and enhanced, providing greater opportunity for the number of artists and volume of content to increase.

“There have been significant achievements at almost every turn as we build on the initial wave of response to the Fan Pass offering, and adding artists who have a significant base of fans and followers is always something we are keen to do,” said Friendable CEO Robert A. Rositano Jr. “The latest round of sign-ups has brought three such artists to the forefront, and our team is excited to launch their channels so we can test their reach and engagement in this regard. The reach of each of these three artists varies, but as you will recognize straight away, this is a big opportunity for our platform to reach their fan bases.”

The three artists Rositano referenced are Hot Boy Turk, Leeky Bandz and Bigga$tate. Hot Boy Turk  brings the largest fan following, with 372,000 fans on a verified Instagram account and 10,400 YouTube subscribers. Leeky Bandz has 44,300 Instagram followers through a verified IG account, 38,702 monthly listeners on Spotify, 17,500 subscribers on YouTube and collabs with artists such as Gunna and YoungBoy Never Broke Again. Bigga$tate has 21,500 Instagram followers and 6,607 monthly listeners on Spotify; his most recent music video received more than 40,000 views.

Friendable is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. With Fan Pass, artists can offer exclusive content channels to their fans, who can simply use their smartphones to gain access to their favorite artists as well as all-access passes that provide access to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists.

For more information, visit the company’s website at www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Recent report estimates EEG equipment market will grow at 4.5% CAGR reaching $1.99 billion by 2026
• Driving forces include aging population, technological advances, increased use in neonatal intensive care units
• BRSF well-placed to capitalize on market’s robust growth

A recent report published by Allied Market Research estimates that the global electroencephalography (“EEG”) equipment market was $1.4 billion in 2018 and is expected to reach $1.99 billion by 2026, growing at a CAGR of 4.5% from 2019 to 2026 (https://ibn.fm/Jmxjq). As a commercial-stage, healthcare company dedicated to developing innovative medical devices in the neurological diagnostics space, Brain Scientific (OTCQB: BRSF) seems well placed to capitalize on the growing EEG equipment market.

The key driving forces behind the market growth include factors such as the aging population, which leads to the increase in demand for brain diagnostics due to neurological diseases, as well as the increase in adoption of EEG equipment in surgery centers coupled with technological advancements in this field. In addition, the rise in the incidence of neurological disorders such as epilepsy and Alzheimer’s disease also contributes to the increase in demand for EEG equipment.

The Allied Market report cites the disease diagnosis segment as the largest EEG equipment market segment measured by the market share and also the fastest-growing one due to the surge in prevalence of neurological disorders across the globe. The increase in adoption of EEGs in neonatal intensive care units is expected to be another major driving force behind the rapid growth of the diagnostic segment.

The demand for neurological diagnostic services is growing rapidly. Still, the supply of trained neurologists remains limited, resulting in significantly limited access to neurological care globally including in developed countries. This is where Brain Scientific’s solutions shine. BRSF has developed two FDA-cleared products: NeuroCap, a disposable, pre-gelled EEG headset that can be applied easily and quickly, and NeuroEEG, a lightweight, wireless, portable EEG amplifier for high-quality EEG tests.

Apart from designing solutions that address the needs of patients with neurodegenerative diseases such as Alzheimer’s, Brain Scientific is developing product line extensions to address the growing pediatric market, which the report also cites as one of the key factors contributing to the EEG equipment market growth. As a company dedicated to developing breakthrough EEG technology to solve the shortage in neurological care, Brain Scientific seems well positioned within the EEG equipment market to benefit from the growing unmet need for the brain diagnostics market.

For more information, visit the company’s website at www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• PowerTap Hydrogen Fueling Corp. (“PowerTap”) engages services of NASA-based hydrogen engineering firm, Cryotek
• Hydrogen fuel cell vehicle market forecasted for CAGR of 66.9% from 2019 to 2026 and projected to reach $42 billion by 2026, according to Allied Market Research (https://ibn.fm/ejitO)
• PowerTap plans to install an initial 500 hydrogen filling stations in California and an additional 500 hydrogen filling stations over next three to five years in other parts of the USA.
• Clean energy expert Greg Nuttall appointed to the PowerTap advisory board.

The announcement by Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) that its investee company, PowerTap, has engaged NASA-based hydrogen engineering firm, Cryotek, as an engineering design partner will give an added fillip to the value of Clean Power’S investment in the fast-growing hydrogen fuel-cell vehicle market. Clean Power Capital is an investment holding company with investments in the health industry and renewable energy industry, has recently increased its focus on opportunities in the renewable energy industry, including fuel-cell technologies. The collaboration between PowerTap and Cryotek will advance PowerTap’s efforts to commercialize its patented hydrogen filling technology, and therefore increase the value of Clean Power’s investment in fuel-cell technologies and PowerTap.

PowerTap is aiming to deploy hydrogen fueling units at existing truck stops and gas stations across the USA, with an initial deployment of up to 500 units in California. Including the initial expansion of up to 500 stations in California, PowerTap has set a target of up to 1,000 stations stations in total, within the next three to five years throughout the USA. To bolster its expertise in this area, PowerTap has appointed Greg Nuttall, one of the clean energy sector’s most foremost figures, to its advisory board. With rapid growth projected for the adoption of hydrogen fuel-cell power systems, PowerTap appears to have hitched its wagon to a star.

The hydrogen fuel cell vehicle market is forecasted to undergo a CAGR of 66.9% from 2019 to 2026, reaching $42 billion by the end of the forecast period (https://ibn.fm/Z2czd). Rising concern over the environmental impact of fossil fuels and an increase in government’s support of hydrogen fuel-cell infrastructure are two of the factors fueling industry growth.

PowerTap has engaged the services of Cryotek, a company focused on developing cryogenic solutions for NASA (USA National Aeronautics and Space Administration) and the U.S. Department of Energy (https://ibn.fm/qTffv). Cryotek is also working to add liquid hydrogen to the list of energy sources for vehicles in the future. As a result, the company has developed proficiency in the design of smaller hydrogen steam methane reformation (“SMR”) units.

Cryotek’s mandate includes the following:

• Next-generation PowerTap Onsite Steam Methane Reformer (“SMR”) solution capable of producing 1,000kg+ per day
• Gaseous and liquid hydrogen storage solutions
• CO2 capture solutions
• Advanced hydrogen dispensing unit
• Artist rendition of proposed final hydrogen filling station.

SMR units combine methane and steam at high pressures to produce hydrogen. The hydrogen produced in the process, known as natural gas reforming, can power fuel cell electric vehicles (FCEVs), cutting total greenhouse gas emissions in half and reducing by over 90% the amount of gasoline in use today. The hydrogen filling units will be capable of producing more than 1,000 kilograms of hydrogen on a daily basis.

As the commercialization of the PowerTap technology picks up, PowerTap has asked Nuttall to sit on its advisory board (https://ibn.fm/nIWgq). Nuttall is an experienced clean-energy executive. He founded the world’s first waste-to-fuel company, Woodland Biofuel, which has received funding from the Canadian federal government as well as private investors. Nuttall was formerly a merchant banker. He is a corporate finance lawyer who obtained a master of international laws degree from Cambridge University.

For more information, visit the company’s website at www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

• In July 2020, CannAssist International became among the first U.S.-based CBD companies to have its securities listed for trading onto a U.S. public capital market
• Xceptor Labs uses proprietary technology to create CBD products that it believes have better absorption than currently marketed oil-based products
• The company currently has five creams that utilize ingredients with National Drug Codes that are registered with the FDA
• The company’s Xceptol line of topical pain cream products, formulated using its proprietary CiBiDinol technology, was launched in September 2020. The company has since added capsules and, very soon, tinctures and pet drops
• The company’s marketing structure for Xceptol includes social media campaigns featuring celebrities and former athletes represented through Freedman Sports Promotional Relations
• CannAssist is currently targeting North America, Central America, South America, South Africa, the EU, the UK and the Philippines as viable product markets
• Strategic partnerships have already collaborated in sourcing, manufacturing, processing, laboratory, distribution, public relations and legal representation
• The global market for cannabidiol is expanding steadily and is forecast to reach $23.6 billion in 2025

CannAssist International (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand. CannAssist, a Delaware corporation, was established in May 2017 and is headquartered in San Diego County, California. 2018 Farm Bill and CBD Market Size Signed into law in December 2018, the Agriculture Improvement Act of 2018 (2018 Farm Bill) removed hemp from its classification as a Schedule I drug under the Controlled Substances Act of 1970. There are over 100 known cannabinoids within the hemp plant. The two most commonly utilized cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). Cannabinoids have been shown to affect the endocannabinoid system within the human body, which is why CBD has demonstrated effectiveness as a therapeutic option when delivered through the right absorption avenues. The 2018 Farm Bill is expected to have a sustained impact on the growth of the cannabidiol market and related sectors. In 2018, the global cannabidiol market was valued at $4.6 billion, and it’s expected to increase almost sixfold by 2025, reaching $23.6 billion (https://ibn.fm/PL6PO). This growth is expected to provide multiple opportunities to CannAssist and its high-quality, high-performance brands, including products currently under development. Based on current revenue from licensing agreements, retail sales and the Xceptol brand’s international distribution, the company expects to reach first-year sales of $5 million. With additional products in the pipeline and an unwavering commitment to quality and effectiveness, the company expects to see steady sales growth in the years ahead. Xceptor Labs Xceptor Labs is an R&D and raw material manufacturing company that partners with TakaUSA, in Coppell, Texas, for contract manufacturing and production services. CiBiDinol Technology Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CannAssist Founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products. CiBiDinol is believed to provide CBD in a format that is more in line with the body’s natural bioactivity. The company’s proprietary processes are used to combine CBD molecules with penetration enhancing cyclodextrin, effectively modifying the CBD molecule’s surface and rendering it water dispersible. This technology enhances absorption through the skin and gut. The company believes that CBD products created using its CiBiDinol technology offer more predictable potency and enable reduced dosage requirements. This technology clears the way for a wide variety of products, including many oil-soluble active ingredients and highly effective consumer product applications. Independent Testing Third-party testing has confirmed that products made with CiBiDinol demonstrate a 400 percent increase in skin penetration as compared to regular CBD in oil carriers alone, as well as a 300 percent higher absorption rate in the gut. The company believes that the results indicate that the amount of CBD needed to achieve targeted endpoints can be significantly lower, resulting in lower costs for manufacturers and consumers with little to no side effects. “Oversight of manufacturing and third-party testing of this ingredient produced consumer products designed to provide clinicians and consumers safe, effective, and affordable treatment options to address their health and wellness concerns,” Palumbo said in a news release. CiBiDinol is currently being evaluated for safety by the National Science Foundation for Global Recognition and has been submitted to the FDA’s bulk drug substance program. The company is developing a commerce pathway in each state’s pharmaceutical distribution network through the National Board of Pharmacies. The company aims to capture increasing market share through product extensions and advancements by seeking critical third-party analysis and physician feedback regarding its proprietary technology’s attributes. Xceptor Labs intends to offer licensing arrangements for brand-consumer companies. Xceptol Products CiBiDinol technology is the foundation for Xceptor Labs and the Xceptol line of products, including topical creams, capsules, tinctures and pet drops. The Xceptol line began launching its products in September 2020, and it currently has five National Drug Code topical pain creams utilizing ingredients registered with the FDA. Xceptol products will be sold online, through Range Me, as well as through national and international retail and pharmaceutical distributors. Marketing for Xceptol products is planned through multiple social media campaigns including using celebrities and former athletes associated with Freedman Sports Promotional Relations. Xceptol is establishing sales channels in North America, Central America, South America, South Africa, the EU, the UK and the Philippines. Management Team Mark Palumbo, CEO and Founder, is an entrepreneur, scientist and executive with over 30 years in the health care, laboratory and manufacturing industries. His entrepreneurial endeavors include a successful personal care industry distribution company, a currently owned and operated tissue culture laboratory and Xceptor Labs, now part of CannAssist International. Marla Palumbo, President, is a health care professional and registered nurse with over 30 years of experience in the industry. She handles sales, patient advocacy, patient care and general management. Marla Palumbo has effectively developed and grown a personal care distribution company with significant year over year increases in sales. Her management and organization skills were instrumental in the early development of Xceptor Labs, leading to its CannAssist International public company status. Dr. Rahul Dixit, MD, Medical Director, is a doctor of gastroenterology at Providence St. John’s Medical Center in Santa Monica, California. He was part of a double fellowship with the University of Miami in Gastroenterology and Hepatology/Liver Transplant at Johns Hopkins Hospital. He has over 20 years of experience with cannabis and hemp-related products. Takako McGowan, Managing Director, Founding Member and Owner of TakaUSA, brings 40 years of experience in manufacturing and consumer product research & development to the CannAssist team. Camron Elizabeth, Managing Director-Sales and Marketing, is an entrepreneur and leader who has brought immense success to the companies with whom she has worked. As Founder and CEO of Platinum Pack, Elizabeth was responsible for all aspects of its success in bringing products from concept to completion and successful sell-through on the retailer’s shelf. She has been in the beauty industry for over 40 years. Benjamin Perlstein, VP of Operations, has been a part of the health care and business development field for over 25 years. As a surgical technologist, he has experience as a clinical application specialist and materials manager. Braden Traub, Director of Marketing and Customer Development, is an entrepreneur and business owner with 10 years of experience in the health and fitness industries. Traub also has skills and experience as a tax resolutionist and legal document preparer. For more information, visit the company’s website at www.CannAssistInternational.com. NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC Safe Harbor for Forward-Looking Statements Forward-looking statements are inherently subject to risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, the following: the timing and nature of any capital raising transactions; the Company’s ability to offer products and services for use by customers in existing and new markets; the Company’s ability to deliver in a timely fashion and to its customers’ satisfaction the products purchased; the risk of competition; its ability to find, recruit and retain personnel with knowledge and experience in selling products and services in existing and new markets; its ability to manage growth; and general market, economic and business conditions. Additional factors that could cause actual results to differ materially from those anticipated by the Company’s forward-looking statements are under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in its Annual Report on Form 10-K for the fiscal year 2019 and its subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all filed with the Securities and Exchange Commission. Forward-looking statements are made as of the date hereof, and the Company expressly disclaim any obligation or undertaking to update forward-looking statements.

• Knightscope provides the latest technological tools to law enforcement.
• Knightscope autonomous security robots (ASRs) can spot bad actors.
• Knightscope currently has three ASRs available.
• ASRs, supporting technologies all made in the United States.

Knightscope is out to make the United States of America the safest country in the world. The company, based in California’s Silicon Valley, is a pioneering developer of autonomous security robots (“ASRs”) designed to support human security and law enforcement personnel. Recently, Knightscope chairman and CEO William Santana Li sat down with Chris Lahiji, president of LD Micro, for a wide-ranging interview that covered the company’s genesis, its scorecard in raising capital and its ambitious goal to reimagine public safety. Li is a veteran entrepreneur and former corporate executive of Ford Motor Company. He is also the founder of GreenLeaf, now part of LKQ Corporation (NASDAQ: LKQ), a company that became the world’s second-largest automotive recycler. The Knightscope name, he explained, combines two themes. Knight is meant to signal the protection of the innocent so often associated with medieval knights in shining armor. That idealism is also apparent in Li’s ambitious goal “to make the United States of America the safest country in the world.” Second, scope means “to look at carefully” or to “investigate.” Knightscope wants to provide law enforcement and security personnel with “smart eyes and ears” so they can do their job more effectively. The company is well on its way to doing just that. It recently signed contracts with a number of utilities, casinos, hospitals, and municipalities and inked its first contract with the federal government earlier this year. The global pandemic has intensified pursuit of new paradigms of public safety. New tools, technologies and processes are needed to support the thin blue line of law enforcement. Li explained how thin that line really is. There are, he said, about a million law enforcement professionals and a million security guards. That’s two million people whose services must cover a 24/7 period. Consequently, at any one time, only one-fourth of that pool is available as humans cannot be triple-shifted. In reality, on a daily basis, “there are only five hundred thousand humans trying to secure 328 million Americans across 50 states,” Li noted. “That math just doesn’t work. And that’s why crime has a trillion-dollar negative economic impact on the U.S. every single year. It’s a hidden tax that we all pay in blood, tears and treasure.” In the United States, the armed forces are supported by a huge military industrial complex and a centralized procurement agency, the Department of Defense. However, apart from the FBI, the law enforcement sector is relatively devoid of such coordinated assistance. “The U.S. Departments of Justice and Homeland Security have no jurisdiction over 19,000 law enforcement agencies and 8,000 private security firms,” says Li. The result is that state and municipal law enforcement personnel lack the latest technologies and tools available to their peers in the military. Knightscope is intent on stepping into the breach. The company has developed robots that can read 1,200 license plates per minute, recognize an individual through facial features, run a thermal scan, check for rogue mobile devices and much more. Knightscope has already brought three ASRs to market: The K1 is a stationary robot that can be used at entrance and exit points, ideal for spotting already- identified bad actors. The K3 and K5 robots can move around. The K3 is designed for indoor use; the K5 for use outside. The Knightscope autonomous security robots (“ASRs”) work best in conjunction with human security guards. Not only does their presence discourage criminal activity, but the robots act as extra eyes and ears that monitor the behavior of individuals and crowds. Moreover, their ability to record and amass data means that an ASR can retain a “memory” of events that no human can match. Deploying one is like having a cyborg for a security guard. The ASRs and all related technologies were developed domestically by Knightscope and manufactured in the United States. For more information, visit the company’s website at www.Knightscope.com. Visit https://www.knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

• “Gold Investing News” cites project quality, management experience as key factors contributing to succes
• Project quality is jurisdiction–related with transparent permitting, well-developed infrastructure being critical
• GOH operates assets in Chile and Canada, led by experienced management team

An article published by “Gold Investing News” cites quality projects and strong management teams as major factors determining the success of junior exploration companies as they navigate economic downturns (https://ibn.fm/Attdv). GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF), a Canadian junior mining company, is well equipped with strength in both areas and is poised to capitalize on those strengths as investors seek de-risking in the current volatile environment. The ability of junior mining companies to attract capital is closely tied to the quality of projects in favorable jurisdictions and to the knowledge and expertise of its executive team to navigate a challenging financial environment. In an uncertain financial climate, investors’ general risk appetite decreases as they look for less volatility and more security. In conditions like these, de-risked projects become attractive. However, de-risking starts at the jurisdictional level with transparent permitting and well-developed infrastructure as key factors. Management strength, as reflected in an experienced leadership team with a proven track record, including considerable exploration and development experience, also significantly de-risk the project in investors’ eyes. As a junior mining company led by a seasoned executive team with mining assets located in stable political jurisdictions, GoldHaven Resources is poised to thrive in today’s mining environment. The company believes that the ultimate corporate success is dependent on the right people, the right product, and the right time combined with a strong commitment (https://ibn.fm/OIXYZ). As a junior exploration company, GoldHaven is active in the Maricunga Gold Belt located in Northern Chile, hosting more than 100Moz of gold, 450Moz of silver and 13Blbs of copper. In addition to its properties in the prolific Maricunga Gold Belt, GOH also operates Canadian projects, including the first phase of the 2020 exploration program on its Adam West property located in Vancouver Island, British Columbia. With key people who leverage decades of experience and successes in the mining industry and the corporate strategy focused on identifying and capitalizing on precious metal projects in mineral-rich districts within stable political jurisdictions, GoldHaven seems well placed to offer the strengths investors tend to look at in these uncertain times. For more information, visit the company’s website at www.GoldHavenResources.com. NOTE TO INVESTORS: The latest news and updates relating to ATUMF are available in the company’s newsroom at http://ibn.fm/ATUMF

• Energy Fuels has produced rare earth element (“REE”) concentrate on a pilot scale at wholly owned White Mesa Mill.
• The high-purity concentrate is ready to send to separation plant for final acceptance test work.
• Company used existing infrastructure and technologies, thereby avoiding years of permitting and development, as well as need for significant capital.

Energy Fuels (NYSE American: UUUU) (TSX: EFR) has produced a rare earth element (“REE”) carbonate concentrate on a pilot scale at its wholly owned White Mesa Mill, located in Utah (https://ibn.fm/WImVU). This may be the first REE concentrate produced from monazite sands at any significant quantity in North America in more than 20 years. “Energy Fuels achieved a major milestone in U.S. rare earth element production when we successfully produced a REE Concentrate from a sample of monazite sands at our White Mesa Mill,” said Energy Fuels president and CEO Mark S. Chalmers. “Our company literally accomplished REE production in months, because we utilized existing resources, infrastructure and technologies. While it is still early days, and we still have a lot of work to do, this is a proud moment, not just for me, but for the entire Energy Fuels team who has diligently worked on making REE Concentrate production a reality.” According to the company, the White Mesa Mill recovered the REEs, along with uranium, from one metric tonne of monazite sands. The concentrate is ready to send to a separation plant for final acceptance test work. This milestone came relatively quickly, given that Energy Fuels just entered the REE space in April 2020. In just over six months, the company moved from laboratory-scale testing to producing pilot-scale REE Concentrate from a one tonne sample of monazite sands. The company possesses three tonnes of additional monazite sands samples, which it will use to further refine the process for recovering REEs and uranium from these types of ores. The rapid progress made by Energy Fuels is reflective of its commitment to re-establish the ability of the U.S. to recover REEs and uranium from monazite sands using existing facilities and technologies. Additionally, as part of this commitment, the company is in negotiations to obtain additional sources of monazite sands for potential processing on a commercial scale at the Mill. Energy Fuels is also exploring the potential sale of REE Concentrate to a REE separation facility. “By using existing infrastructure and technologies at the Mill to recover the uranium and the REEs from monazite sands, we are able to avoid the years of permitting and development, along with the tens, or even hundreds, of millions of dollars of capital that others would be faced with,” Chalmers said. “Assuming the company is able to secure adequate quantities of monazite sands, we expect to be in a position to produce commercial quantities of REE Concentrate by early 2021. “Energy Fuels will always, first and foremost, be a uranium producer,” Chalmers continued. “We have been the number one uranium miner in the U.S. since 2017, a position we intend to keep for many years to come. However, when other complementary business opportunities arise with the potential to create significant cash flow utilizing our existing facilities and workforce, we will always take a hard look at them with an eye toward building shareholder value. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• State recreational marijuana market on track to top $1 billion
• Michigan could be fastest-growing recreational market per capita outside of California
• Gage’s current portfolio features 19 Class C cultivation licenses across four cultivation assets, three processing licenses

In only one year, Michigan’s new recreational marijuana market is projected to reach — and exceed — $1 billion, second only to California (https://ibn.fm/q80zU). That is good news for Gage Cannabis, a leading vertically integrated operator in the cannabis industry focused exclusively on the Michigan market. “It really is just explosive growth in Michigan,” said Sloane Barbour, the chief revenue officer of cannabis industry recruitment agency FlowerHire. “There was already a robust medical market, in the sense that there was a community and sort of an expectation for a certain level of accessibility when it came to cannabis products. . . .with the new recreational market, you already had a bit more of a normalization or social acceptance, if you will, of cannabis.” Michigan voters approved the medical marijuana market in 2008; a decade later, a 2018 initiative to legalize recreational use passed with 56% of the vote, and state-licensed sales of recreational cannabis began in December 2019. Although other states legalized cannabis earlier, Barbour says that Michigan could be the fastest-growing recreational market per capita outside of California. Recent reports indicate that, in 2020, both medical and recreational sales have increased in the state, totaling an estimated $313.7 million and $281.2 million respectively (https://ibn.fm/aHY4h). Michigan’s recreational marijuana sales exploded more than 500% between January 2020 and September 2020, growing from $9.8 million to $59.7 million. One factor contributing to the increase, says Barbour, was that when much of the economy shut down because of the coronavirus pandemic, Michigan’s marijuana industry was categorized as essential. “With the pandemic where people are spending more time indoors without as much to do with a lot of anxiety, people will always self-medicate,” Barbour said. “Traditionally that’s been alcohol, and unfortunately it also can be things like opioids. But more and more, we’re seeing people turn to the cannabis plant, which is a healthier, safer alternative to sort of those other anti-anxiety medications. The state’s burgeoning growth was one of the reasons Gage decided to set up shop in Michigan. Gage opened its first medical provisioning center (dispensary) in 2019, and the company now has 13 medical or adult-use locations in operation or planned. Additional locations are slated to open in 2021. Gage’s current portfolio features 19 Class C cultivation licenses across four cultivation assets and three processing licenses. Gage Cannabis Co. is innovating and curating the highest-quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market. Through years of progressive industry experience, the firm’s founding partners have successfully built and grown operations with federal and state licenses, including cultivation, processing and retail locations. Gage’s portfolio includes city and state approvals for 19 Class C cultivation licenses, three processing licenses and 13 provisioning centers (dispensaries). Gage Cannabis has recently announced its intentions to raise up to $50 million in gross proceeds through a regulation A+ offering (https://ibn.fm/Edhda), with a portion of the proceeds set to be re-invested to finance the company’s various growth initiatives. With Michigan’s cannabis market set to expand exponentially in the coming years, Gage Cannabis finds itself well-positioned to capitalize on market’s future growth trajectory. To learn more about the company’s Regulation A financing, visit www.GageInvestors.com. For more information, visit the company’s website at www.GageUSA.com. NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis are available in the company’s newsroom at https://ibn.fm/GAGE

• SRAX’s Sequire, an investor intelligence platform, seeks to combine investor intelligence services with detailed shareholder insights
• Sequire boasts 91 publicly listed subscribers on its platform along with over 1 million investors and traders
• Sequire’s platform allows companies to track their shareholders’ actions, interact with existing investors, meet with future prospective shareholders
• Company is well-positioned to benefit from increased digitization of global investor relations functions

SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has rapidly emerged as a leader in the field of combining investor intelligence services with detailed shareholder insights. Launched as a stand-alone platform in early 2020, Sequire, SRAX’s SAAS investor intelligence platform, has garnered great popularity, having accrued over 1 million investors and traders. The company has also attracted over 91 publicly-listed companies as subscribers on its platform (https://ibn.fm/1Yunn) – an explosion of growth largely driven by Sequire’s extensive range of services. Increasingly, companies have sought to adopt digital technology and the data generated from such mediums as a way of improving their engagement with customer and stakeholders alike. These insights have assisted companies in developing new products and services while also developing a better understanding of their consumer’s pain points and unmet needs (https://ibn.fm/YWtqe). Sequire has seized upon this trend, harnessing the digital insights provided by the over 1 million investors currently on the company’s platform in a bid to help its corporate subscribers with their individual investor outreach programs. Sequire allows its subscribers to track their shareholders’ selling and buying trends, search and monitor key investors, track outstanding warrants, receive the latest company specific news and media and even create and send out customized shareholder surveys designed to bring forth their stake-holders’ insights and opinions (https://ibn.fm/C7geP). The company’s management illustrated the platform’s potential by outlining one example, where a single corporate subscriber using Sequire has seen their number of individual shareholders skyrocket from 3,000 to over 360,000 during their tenure on the platform. The successes witnessed thus far have now led the Sequire SAAS platform to record six consecutive quarters of growth. “The growth we experienced this last quarter and through today has been the fastest we have encountered as a public company,” said SRAX CEO and founder Christopher Miglino. “For the past six weeks we have closed close to $1M per week in business, mostly driven by our Sequire platform. Public issuers are seeing the benefits of the platform, and our data teams are gaining significant insights from that growth. Sequire now has over 1 million investors and traders, a significant portion of which are from the Robinhood platform.” The business model underpinning corporate investor relations efforts has undergone a radical transformation in recent years, with digitization having now fully arrived in the field. IR websites and digital business reports are now standard, while the use of digital distribution channels for company communications becoming largely indispensable. However, the improvement in technology and greater bandwidth provided as a result has also led to new opportunities being created – webcasts and virtual events are allowing companies to communicate and interact with investors located in distant geographies while also providing a medium for investors to come into direct contact with corporate representatives. Over time, big data and artificial intelligence are set to become ever more significant factors governing the development of the investor relations function – providing issuers with greater insights into their end investors while simultaneously allowing them to personalize their end interactions with the latter group (https://ibn.fm/8hptj). The recognition of these upcoming changes has underpinned the ongoing development of the Sequire platform, ideally placing it to benefit from the ongoing radical transformation of the global investor relations industry. For more information, visit the company’s website at www.SRAX.com NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX